Cevimeline is a parasympathomimetic agent that act as an agonist at the muscarinic acetylcholine receptors M1 and M3. It is indicated by the Food and Drug Administration for the treatment of dry mouth associated with Sjögren's syndrome.
用于治疗各型青光眼。FDA批准用于干燥综合征和放疗引起的口干症。
Novum Pharmaceutical Research Services, Las Vegas, Nevada, United States
Novum Pharmaceutical Research Services, Las Vegas, Nevada, United States
University of Kentucky Orofacial Pain Center College of Dentistry, Lexington, Kentucky, United States
Fauquier ENT Consultants, Warrenton, Virginia, United States
Commonwealth Ear, Nose and Throat, Louisville, Kentucky, United States
Associated Otolaryngologist, Palmyra, Pennsylvania, United States
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.